Patrick Mauro Investment Advisor INC. lowered its stake in CME Group Inc. (NASDAQ:CME - Free Report) by 6.4% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 50,306 shares of the financial services provider's stock after selling 3,454 shares during the period. CME Group accounts for approximately 7.3% of Patrick Mauro Investment Advisor INC.'s holdings, making the stock its biggest holding. Patrick Mauro Investment Advisor INC.'s holdings in CME Group were worth $13,346,000 as of its most recent SEC filing.
Several other large investors have also added to or reduced their stakes in CME. West Family Investments Inc. lifted its position in CME Group by 2.4% during the first quarter. West Family Investments Inc. now owns 2,143 shares of the financial services provider's stock valued at $569,000 after buying an additional 50 shares during the period. Leo Wealth LLC lifted its position in CME Group by 13.4% during the first quarter. Leo Wealth LLC now owns 1,783 shares of the financial services provider's stock valued at $473,000 after buying an additional 211 shares during the period. Massachusetts Financial Services Co. MA lifted its position in CME Group by 29.9% during the first quarter. Massachusetts Financial Services Co. MA now owns 2,818,590 shares of the financial services provider's stock valued at $747,744,000 after buying an additional 648,591 shares during the period. Dakota Wealth Management raised its position in shares of CME Group by 126.4% in the 1st quarter. Dakota Wealth Management now owns 6,017 shares of the financial services provider's stock worth $1,596,000 after purchasing an additional 3,359 shares during the last quarter. Finally, OVERSEA CHINESE BANKING Corp Ltd purchased a new position in shares of CME Group in the 1st quarter worth about $718,000. Institutional investors own 87.75% of the company's stock.
Insider Buying and Selling at CME Group
In related news, Director Phyllis M. Lockett sold 1,060 shares of the business's stock in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the transaction, the director directly owned 3,108 shares in the company, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Daniel G. Kaye sold 500 shares of the business's stock in a transaction that occurred on Thursday, May 22nd. The shares were sold at an average price of $282.42, for a total value of $141,210.00. Following the transaction, the director owned 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,400 shares of company stock worth $3,680,610. 0.30% of the stock is owned by corporate insiders.
CME Group Stock Performance
Shares of CME Group stock traded down $3.18 during trading hours on Friday, reaching $274.65. 1,302,431 shares of the stock traded hands, compared to its average volume of 2,175,447. The company has a 50 day moving average price of $276.08 and a 200 day moving average price of $260.36. The firm has a market capitalization of $98.97 billion, a price-to-earnings ratio of 27.64, a P/E/G ratio of 4.86 and a beta of 0.44. CME Group Inc. has a one year low of $193.25 and a one year high of $290.79. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings results on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The business had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a return on equity of 14.03% and a net margin of 57.71%. The business's quarterly revenue was up 10.4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.50 EPS. On average, equities research analysts expect that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th were paid a dividend of $1.25 per share. The ex-dividend date was Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.82%. CME Group's dividend payout ratio is currently 50.30%.
Wall Street Analysts Forecast Growth
CME has been the subject of several recent analyst reports. Barclays lifted their price target on CME Group from $283.00 to $299.00 and gave the stock an "equal weight" rating in a research report on Thursday, July 10th. Citigroup lifted their price target on CME Group from $265.00 to $275.00 and gave the stock a "neutral" rating in a research report on Thursday, July 3rd. Oppenheimer lifted their price target on CME Group from $282.00 to $300.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Piper Sandler lifted their price target on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a research report on Tuesday. Finally, Morgan Stanley lifted their price target on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a research report on Thursday, April 24th. Four research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, CME Group has a consensus rating of "Hold" and a consensus price target of $261.80.
View Our Latest Analysis on CME
CME Group Company Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More

Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.